Genmab — November 2017
-
PBH..Derfor er Genmab faldet 15% de seneste tre måneder: https://play.borsen.dk/social/5a08a59f45628ff817212e99
-
Janssen Korea’s ‘paradigm-changing’ blood cancer drug gets approval http://www.koreabiomed.com/news/articleView.html?idxno=1878
-
and if you speak chinese; Darzalex entered the Top100 sales worldwide for the first 9months of the year http://www.chinapharm.com.cn/News/Detail.aspx?ID=39600 or via google translate https://translate.google.nl/translate?hl=nl&sl=zh-CN&tl=en&u=http%3A%2F%2Fwww.chinapharm.com.cn%2FNews%2FDetail.aspx%3FID%3D39600
-
Ham Per Hansen skal man vist ikke tage alt for seriøst - 15% fald over 3 måneder på basis af JJ's Q3 rapportering...
-
I øvrigt, så må udlandet udsalg af GEN aktier over den seneste måned have været ret markant, hvis man tager BlackRocks ~2% point forøgelse i betragtning
-
mon ikke snarere der var tale om 20% på en måned?
-
eftersom det event han hentyder til, skete for 1 måned siden
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind